The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.

Varda Space Industries, which is leveraging reusable rockets to manufacture drugs in low Earth orbit, has received more fuel for its endeavors in the form of a $187 million series C fundraising haul.

The SpaceX program is still in the early stages of development and the plans could change. The effort is highly reliant on ...

NASA officials remain eager for Starliner to begin these regular crew rotation flights, even as its sole destination, the ISS ...

Varda Space Industries raises funds to produce drugs in outer space; the Food and Drug Administration rejected Capricor Therapeutics’ application for its cell therapy for Duchenne muscular dystrophy; ...

In Ari Aster’s dark comedy, Joaquin Phoenix plays the sheriff of a New Mexico town riven by political clashes and pandemic ...

New York City — and specifically Manhattan — was understood to be the Prime Target and hence Ground Zero in a nuclear war.

Venture capital companies remained the most active space investors in recent months, contributing 77% of 2025 funding in the ...

In this week’s edition of The Prototype, we look at a new company building automated construction equipment, a potential new ...

Firms downgrade 2025 outlook, isocyanate start-up launches, hydrogen projects advance, and more ...

The alliance brings together Cellular Origins, a company focusing on applying robotics and other forms of automation to CGT ...

AST SpaceMobile (ASTS), Planet Labs (PL), and BlackSky (BKSY) have been on a tear lately. Since early April, all four of these names have more than doubled – in just three months – led by a nearly 215 ...